Sapna Patel

基本信息

浏览量：121

职业迁徙

个人简介

Skills
Oncology
Social Media Blogging
Clinical Research
Cancer
Scientific Writing
Medical Education
Healthcare
Translational Research

研究兴趣

论文共 324 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Keratosis Pilaris-Like Reaction Associated with Chromatin Remodeling Complex Inhibition in Uveal Melanoma

Riyad N. H. Seervai,Madison M. Taylor,Ziba Rahbar,Sapna P. Patel,Kelly C. Nelson,Victor G. Prieto, Jonathan L. Curry

JAMA Dermatology (2024)

引用0浏览0WOS引用

Abstract 3607: Case Study: Efficacy and Persistence of Autologous T Cell Therapy Targeting SLC45A2 in Uveal Melanoma

Shailbala Singh,Esther Ryu,Katie M. Campbell,Amber Smith,Suzanne Phillips, Luisa Soto,Ivy Lai,Gregory Lizee,Benjamin Vincent, Marshall Thompson,William Hoos,Sapna Patel,Cassian Yee

Cancer Researchno. 6_Supplement (2024): 3607-3607

引用0浏览0引用

28P Decoding biomarkers of immune activation in neuroendocrine carcinomas treated with ipilimumab and nivolumab using a multiomic approach

C. Haymaker, G. Kumar,Y.K. Chae, E. Gonzalez-Kozlova, C. Duault, J. Zhang,M. Othus, L. Solis Soto, G. Manyam, P. Jiang,E.R. Parra, C. Laberiano Fernandez,A. Reuben, H. Maecker, S. Gnjatic, G. Al-Atrash, J. Zhang, J.J. Lee,S.P. Patel, R. Kurzrock

ESMO Open (2024)

引用0浏览0引用

687 ACTengine IMA203 TCR-T Targeting PRAME Shows Deep and Durable Anti-Tumor Activity in Heavily Pretreated Solid Cancer Patients

Martin Wermke, Winfried Alsdorf, Dejka M Araujo, Manik Chatterjee, Oliver Ebert, Leonel Hernandez-Aya, Norbert Hilf, Tobias AW Holderried,Amir A Jazaeri, M Alper Kursunel, Andrea Mayer-Mokler, Regina Mendrzyk,Ali Mohamed,Sapna Patel, Ran Reshef, Apostolia Maria Tsimberidou,Steffen Walter, Toni Weinschenk,Jason J Luke, Cedrik M Britten

Regular and Young Investigator Award Abstracts (2024)

引用0浏览0引用

Dual Immune Checkpoint Inhibition in Melanoma and PD-L1 Expression: the Jury is Still Out

Andreas Michael Schmitt,James Larkin,Sapna P Patel

Journal of clinical oncology official journal of the American Society of Clinical Oncologypp.JCO2401572-JCO2401572, (2024)

引用0浏览0WOS引用

Phase II Trial of Weekly or Bi-Weekly Tocilizumab with Ipilimumab and Nivolumab in Advanced Melanoma: Clinical Outcomes and Biomarker Analysis

Bilal Anouti, Krysta McVay, Manjusha Abraham,Daniel H. Johnson,Rodabe Navroze Amaria, Christine Spillson, Isabella Claudia Glitza,Sapna Pradyuman Patel, Michael K. K. Wong, Jennifer Leigh McQuade,Hussein A. Tawbi,Michael A. Davies,Alexandra Ikeguchi, Salah-Eddine Bentebibel, Reham Abdel-Wahab, Khaled M. Elsayes, James Patrick Allison,Padmanee Sharma, Noha Abdel-Wahab,Adi Diab

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Abstract CT267: Temsirolimus (T) in Patients (pts) with Solid Tumors with AKT1/3 Amplification (amp) or Mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study